tiprankstipranks
Fulcrum Therapeutics (FULC)
NASDAQ:FULC
US Market
FULC
Fulcrum Therapeutics
RESEARCH TOOLSreports
Want to see FULC full AI Analyst Report?

Fulcrum Therapeutics (FULC) Income Statement

521 Followers

Fulcrum Therapeutics Income Statement

Last quarter (Q4 2025), Fulcrum Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Fulcrum Therapeutics's net income was $-20.33M. See Fulcrum Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 80.00M$ 2.81M$ 6.34M$ 19.16M
Gross Profit
$ -1.39M$ 78.41M$ 2.81M$ -70.44M$ -50.54M
Operating Expenses
$ 83.38M$ 38.51M$ 113.47M$ 42.12M$ 30.52M
Depreciation and Amortization
$ 1.39M$ 1.59M$ 2.17M$ 2.41M$ 2.52M
EBITDA
$ -73.49M$ -18.24M$ -108.49M$ -109.72M$ -78.54M
Operating Income
$ -84.77M$ -21.90M$ -110.66M$ -112.56M$ -81.05M
Other Income/Expenses
$ 9.89M$ 12.17M$ 13.33M$ 2.69M$ 207.00K
Pretax Income
$ -74.88M$ -9.72M$ -97.33M$ -109.87M$ -80.85M
Net Income
$ -74.88M$ -9.72M$ -97.33M$ -109.87M$ -80.85M
Per Share Metrics
Basic EPS
$ -1.18$ -0.16$ -1.59$ -2.35$ -2.22
Diluted EPS
$ -1.18$ -0.16$ -1.59$ -2.35$ -2.22
Weighted Average Shares Outstanding
 63.35M 61.98M 61.31M 44.99M 35.36M
Weighted Average Shares Outstanding (Diluted)
 63.35M 61.98M 61.31M 44.99M 35.36M
Currency in USD

Fulcrum Therapeutics Earnings and Revenue History